REVB
NASDAQ
$1.15
Revelation Biosciences Inc (REVB)
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $19.25 (+1573.91%)
Market Cap
$4.26M
P/B Ratio
0.31
Price Chart
Valuation
Market Cap$4.26M
Forward P/E0.89
P/S2.88
P/B0.31
Profitability
Gross Profit (TTM)$91M
EBITDA-$10M
EPS-$4.66
Growth & Risk
Sharpe Ratio-2.64